Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Veterans Affairs
Grant: I01BX004903 , IK6BX004855 , I01BX002922
National Institutes of Health
Grant: F30CA236031, R01CA217907 , R21CA255291 , R01CA242003
BLRD VA
Grant: IK6 BX004855
NCI NIH HHS
Grant: F30 CA236031
NCI NIH HHS
Grant: R01 CA242003
BLRD VA
Grant: I01 BX004903
NCI NIH HHS
Grant: R21 CA255291
NCI NIH HHS
Grant: R01 CA217907
BLRD VA
Grant: I01 BX002922
FWCI
2.79
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals